|
Post-Surgical
Palliation Home Surveillance
DeeAnn Martin, R.N.; Cardiac
Surgery Specialty Nurse, Arkansas Children's Hospital 
Hypoplastic left heart syndrome (HLHS) is a constellation
of defects involving stenosis or atresia of the mitral valve,
hypoplasia of the systemic or left ventricle, severe aortic
valve hypoplasia with atresia, and hypoplasia of the ascending
aorta. Surgical palliation for infants born with HLHS consists
of Stage 1 Palliation (S1P). Also known as the
Norwood procedure, S1P is the construction of an unobstructed
outlet for systemic cardiac output from the right ventricle,
and adequate pulmonary blood flow through a controlled shunt.
In the recent past, late interim mortality between S1P and
Stage 2 Palliation (S2P) ranged from 10 percent to 15 percent. The
Norwood population is considered to be at increased risk
for sudden death from a combination of physiologic variances. Worsening
systemic oxygenation and acute dehydration are variables
which contribute to increased risk for sudden death. Home
surveillance programs, consisting of daily oxygen saturation
monitoring and weight checks, have been shown to decrease
the risk of late interim mortality between S1P and S2P from
10 percent to 15 percent to 0 percent for infants with HLHS.
History of the Program
Since 2002, the ACH Cardiac Surgery department has
monitored each post-Norwood baby with a home surveillance
program. Beginning in 2006, the program was expanded to
include all babies with univentricular hearts palliated
with systemic to pulmonary artery shunts. Home pulse oximeters
and baby scales are provided by the family’s insurance
company and placed in each baby’s home. The primary
caregiver is taught how to correctly obtain an accurate
daily oxygen saturation reading and weight. These measurements
are recorded on a provided form and faxed weekly to the
Cardiac Surgery department. 
Each baby’s growth and oxygen saturation trends are
monitored closely. This information is provided to
the baby’s primary cardiologist and a registered dietician
participating in the program. Thus ongoing assessment
of each palliated infant is achieved by three collaborating
services. Patient participation in the home surveillance
program ceases with achievement of stage 2 palliation.
Obtaining home monitoring equipment is becoming difficult
as more third-party payers are denying coverage. Therefore,
ACH CVICU is providing baby scales as needed for caregivers’ use. We
would be remiss if, after performing advanced surgical intervention
and postoperative care, we did not enable the primary caregivers
to continue high quality care for their babies. We are committed
to reducing interim morbidity and mortality, thus optimizing
each palliated baby’s life course.
Back to Top
Advanced
Practice Nursing at Arkansas Children's Hospital
Michelle McDonnell,
APN; CVICU, Arkansas
Children's Hospital 
An Advanced Practice Nurse (APN) is a registered nurse
who has completed an advanced nursing educational program,
usually at the graduate level, and holds certification
from a nationally recognized certifying body. There
are several specialty areas in which an APN can obtain
certification, including pediatrics. Currently
in the Heart Center, there are five certified Pediatric
Nurse Practitioners (PNP), two of whom have obtained
additional certification as Pediatric Acute Care Nurse
Practitioners. All of the current PNPs obtained
their graduate degree from UAMS and have previous pediatric
nursing experience at ACH. In addition to formal
educational training, PNPs in the Heart Center complete
six months of orientation, working closely with an experienced
nurse practitioner to learn the ICU role.
PNPs are able to directly influence
patient care through the medical management of pediatric
patients, monitoring and ensuring the quality of health
care practice and providing family-centered care. In
addition, they influence practice through staff education,
consultation, research and research dissemination. In
the Heart Center, PNPs work in collaboration with Pediatric
Cardiologists and Intensivists in managing congenital
cardiac patients after surgery.
In collaboration with these physicians, PNPs are able
to perform history and physical examinations, evaluate
clinical data and make appropriate medical decisions,
and perform procedures including management and removal
of arterial and central venous lines, venous and arterial
puncture, endotracheal intubation, umbilical catheter
insertion, needle thoracentesis, defibrillation or cardioversion,
removal of chest tubes, pacing wires, and peritoneal
catheters, and lumbar punctures. The CVICU
team, composed of the attending physician, unit
pharmacist and nurse practitioner, evaluates and assesses
each patient and develops a plan of care for the day. In
addition to taking care of all cardiac ICU patients,
the team is also responsible for any cardiac ECMO patients.
The practitioner team is able to
cover the unit seven days a week with some night coverage,
lending continuity to the CVICU team. Interacting with
families and patients on a daily basis enables the practitioners
to facilitate education and discharge planning based on the individual
needs of the patient. In addition, the practitioner
team works closely with other team members including
the unit pharmacist, social worker, child life specialist,
speech/physical/and occupational therapists to maximize
functional abilities and prevent or minimize disabilities.
Back to Top
Pain
Management after Heart Surgery in the Heart Center
Laura Morales, Pharm. D.; Clinical Coordinator
of the Pharmacy, Arkansas Children's Hospital
At Arkansas Children’s Hospital Heart Center, pain control
is a vital element of the
healing process after surgery. The pain response includes an increase in circulating
levels of catecholamines (adrenalin type chemicals) and hormones leading to
tachycardia (increased heart rate), hypertension (increased blood pressure),
increased oxygen consumption, hypercoagulability (increased blood clotting),
immunosuppression (decreased ability to fight infection) and catabolism (protein
breakdown). Also, lung recovery can be affected when coughing or physical activity
is delayed due to pain.
All patients, including the tiniest newborns, receive analgesics
(pain medicines) with careful monitoring. Narcotic analgesics such as
morphine or fentanyl are first given in the operating room prior to surgery
and continued afterward. Doses are adjusted as needed. While intubated (on
a breathing machine), most patients also receive a benzodiazepine such as midazolam
or lorazepam to lessen their anxiety, promote rest, minimize movement and provide
amnesia. Both types of medications (narcotics and benzodiazepines) may need
to be decreased before extubation (removal of a breathing machine) as they
can suppress the patient’s ability to breath
on their own. A new medication that offers sedation with some analgesia
but without respiratory depression is dexmedetomidine (Precedex). It is not
a narcotic or benzodiazepine but is an alpha 2 agonist (related to clonidine
but more selective) given as a continuous infusion.
Some patients may be candidates for regional (or localized) pain
control measures such as epidural or nerve blocks where local anesthetics and/or
narcotics are given into tissue spaces by an anesthesiologist providing analgesia
with fewer side effects.
Pain Management Administering
Intramuscular injections are painful and are not used for post operative pain
control.
Instead,
patients receive analgesics through their IV (or intravenous line) either
as frequent injections or a continuous infusion. When patients are
able to resume intake of liquids, oral pain medications such as acetaminophen
with codeine (Tylenol with codeine) or oxycodone (Percocet) are given routinely
around the clock or on an as needed basis, depending on the comfort level of
the patient. Constipation is common and can be treated or prevented with laxatives.
Patients 8 years or older may be candidates for “PCA” (or
patient controlled analgesia). A special IV pump is programmed so the patient
can push a button at their bedside allowing the pump to give an IV dose of
analgesic (usually morphine) every few minutes. Sometimes, this is in addition
to a small continuous infusion called a background dose. This allows the patient
to be more in control of their analgesia once they have awakened from general
anesthesia and are alert. Ketorolac (Toradol) is an analgesic similar to ibuprofen
(Motrin) but given through IV. It
is useful in patients who are extremely sleepy or nauseated from narcotics.
Ketorolac is FDA approved for use (in single doses) in patients over 2 years
of age. Patients must be stable from risks of bleeding with normal renal function
for ketorolac to be considered.
Patients who are critically ill and remain intubated for over
a week while receiving morphine, fentanyl, midazolam or lorazepam can develop
tolerance to these agents. Thus, increased doses are needed to provide the
same effect as before. However, once patients are improving, these agents can
be weaned with dosages decreased slowly to prevent withdrawal symptoms of irritability,
tremor, vomiting, sweating, fever or diarrhea. This is termed “physical
dependence” and occurs in all
patients, regardless of age, who receive these agents for prolonged periods.
We treat this by tapering morphine or fentanyl and/or switching to an equivalent
dose of oral methadone. IV midazolam or lorazepam doses are converted to oral
lorazepam. Doses are
decreased every few days and patients are monitored for any further symptoms.
About Addiction
Tolerance and physical dependence alone do not define “addiction,” which
parents may be concerned about until they are educated on the difference. Addiction
is a chronic disease, with behaviors of using a substance in the face of adverse
consequences with loss of control (compulsive use) and a preoccupation with
use (cravings). Genetic, psychosocial and environmental factors must all co-exist
for addiction to occur in any individual. It is not uncommon to see physical
dependence and tolerance from a prolonged recovery, but addiction is quite
rare. Emotional distress from inadequate analgesia is not something we want
our patients or parents to experience. Pain-free recovery after major surgery
is not a reality yet, but minimizing discomfort for our patients is certainly
achievable now.
Back to Top
What is Transposition of the Great Arteries? 
Michiaki Imamura, M.D., Ph.D.;
Pediatric Cardiac Surgeon, Arkansas Children's Hospital; Assistant Professor,
Department of Surgery, University of Arkansas for Medical Sciences College
of Medicine
Our hearts have four chambers inside them (Fig. 1). Under normal conditions,
the blood from the body comes back to the heart into the right atrium. This
blood is relatively blue (deoxygenated) blood. This blue blood goes to the
right ventricle, which pumps the blood to the lungs through the pulmonary artery.
In the lungs, this blood becomes red (oxygenated) blood and returns to the
left atrium. This red blood goes to the left ventricle which pumps it to the
whole body through the aorta. The aorta and the pulmonary artery, the two major
arteries carrying blood away from the heart, are referred to as the “Great
Arteries.”
However, in a patient with transposition of the Great Arteries, the aorta
and the pulmonary artery are switched, and these vessels arise from the wrong
ventricle (Fig. 2). Therefore, blue blood comes back from the body and goes
to the body again, while the red blood comes back from the lungs and goes to
the lungs again.
In the case of transposition of the great arteries, additional
intracardiac anomalies occur, such as ventricular septal defect, pulmonary
valve stenosis, pulmonary artery stenosis, aortic stenosis, coarctation of
the aorta, hypoplasia of the aortic arch and interrupted aortic arch. In the
presence of a ventricular septal defect and pulmonary valve stenosis, a different
surgical treatment is required. The ventricular septal defect is the most common
additional anomaly, except for patent duct arteriosus and an atrial septal
defect. In the presence of other anomalies, treatment is chosen for transposition
of the great arteries.
Signs and Symptoms
Babies with transposition are usually diagnosed as neonates due to cyanosis – blue
coloring of skin, lips and nails. Cyanosis develops in the presence of poor
oxygenation of the red blood cells. Occasionally, a baby with transposition
receives a large amount of pulmonary blood flow and does not show prominent
cyanosis. Without surgical intervention, more than half of infants with transposition
will die in the first month of life, and 90 percent will die in the first year.
Diagnosing
Definitive diagnosis is made by echocardiography. Recently, many patients have
been diagnosed before birth by fetal echocardiography.
Treatment
If there is no shunting (septal defects) inside the heart, a baby with this
disease is not able to survive. This shunting generally occurs due to a hole
between atriums (an ASD). However, some babies do not have this shunt, which
makes their early diagnosis critical in order to prevent early death. In
order to obtain adequate mixing inside the heart, a hole between the right
and left atrium is created or enlarged. This procedure is done by a cardiologist,
who passes a small balloon through a large vein into the heart.
Historically, several surgical interventions are applied to this disease.
In 1959, Dr. Senning invented the new technique of atrial level switching (Fig.
3). 
In 1963, Dr. Mustard invented a surgery similar to Dr. Senning’s,
using a patch to reroute inside the atrium. After these surgeries, the babies
are no longer blue or cyanotic. After this surgery, most patients fared well
for a period of time. However, some patients developed severe heart failure
(heart pumping ability problems) or severe arrhythmia (a heart beating/rhythm
problem). This disappointing result was prominent in the presence of a ventricular
septal defect.
In 1975, Dr. Jatene succeeded with the first arterial switch
operation for transposition. This surgery has two components. One involves
the switching of the great arteries, followed by moving the coronary arteries.
Switching the great arteries means swapping the aorta and the pulmonary artery
(Fig. 4). The coronary arteries are the blood vessels which bring the blood
to the heart itself. In a neonate, the great arteries are sized 1 to 1.5 centimeters
in diameter. However, the coronary arteries are only 1 to 2 millimeters in
diameter. At the time of surgery, these coronary arteries are removed from
the aorta with a cuff of tissue of 5 to 7 millimeters. Then this cuff will
be anastomosed to the original pulmonary artery. Additional anomalies of ventricular
septal defects, atrial septal defects and arch anomalies are repaired as part
of the operation.
Risk factors for an arterial switch operation involve coronary
anomalies, including a single coronary, intramural coronary and unusual coronary
patterns. In the presence of certain cardiac anomalies, such as pulmonary valve
stenosis or left ventricular outflow tract obstruction, an arterial switch
operation is not chosen as the treatment for transposition.
When the patient has a large ventricular septal defect with pulmonary
valve stenosis, a Rastelli type surgery is instituted. A Rastelli type of surgery
is composed of ventricular septal defect closure, and rerouting of the left
ventricle to the original aortic valve, and placement of
a conduit (or tube) between the right ventricle and the pulmonary artery (Fig.
5, 6). This type of surgery has several deficits. First, the patient will require
conduit replacement periodically, secondary to obstruction over time. Secondly,
in the presence of small ventricular septal defect, the patient may develop
left ventricular outflow tract obstruction, which may necessitate further surgical
interventions, as well.
Treatment Results
In the majority of cardiovascular centers, the surgical mortality of arterial
switch operation is less than 5 percent. The patients with the above mentioned
risk factors have a higher mortality rate after arterial switch operations.
Since the left ventricle is used as a systemic ventricle, after arterial
switch operations children usually have normal ventricular functions and
no heart rhythm abnormalities. However, late morbidities include neo aortic
valve insufficiency, left ventricular outflow tract obstruction and coronary
insufficiency.
Back to Top
Spotlight on Jim
Bodtke, RDCS
Cardiac Sonographer, Arkansas Children's Hospital
What is your role at ACH and how long have you worked here?
My role at ACH is to provide cardiac echos for our physicians. I started
here part time in 2002, and became full time soon after.
Why is your job rewarding?
The rewards for me here at ACH come from many different avenues. They
range greatly, from experiencing the grasp of a child’s hand, to a hug
for a job well done, to just being a witness to the love that is freely given
by the staff here at ACH.
How did you become interested in pediatric cardiology or cardiovascular
surgery?
I used to work in an adult lab, but rarely felt that I was making a great impact
on a patient’s outcome, nor did it offer me the variety that pediatrics
could. I became exposed to pediatric cardiology at another institution
and immediately knew what I wanted to do each day.
What do you want people to know about the Heart Center at Arkansas
Children's Hospital?
I would want them to know all the people that are part of the Heart Center
are here for one reason only: Not out of the need for a job, but because
they share a common bond, and that is the children that come here for care,
and that they give that care unselfishly.
What do you enjoy most about working with children?
That’s the easiest question to answer: Making them smile. If you
can achieve getting a pediatric patient to flash you a smile, even briefly,
you know you have made a difference in their day. Besides, for me, that
is the easiest part, as well. I stay pretty much on a child’s level most
of the time.
What has been your most memorable moment working in the Heart Center
at Arkansas Children's Hospital?
The first time I saw a patient without much chance at survival make a full
recovery after receiving a heart transplant. This was the first time
that I felt I was part of something bigger than myself, or even all of us together. Along
with that came the realization that as long as I remain here, I will get to
witness this over and over again.
What is your greatest professional achievement?
Sitting in a lab in Leuven, Belgium, with their world-renowned researchers
and realizing that the research that we are doing at ACH is on par with theirs.
Little Rock, Arkansas – who would have thought?
Jim Bodtke has been instrumental in setting up a new research
study in the Heart Station. His study evaluated strain/strain rate analysis
of the left ventricular myocardium of transplant patients, as an early indicator
of cardiac transplant rejection. Strain/strain rates allow the cardiologist
to study the deformation of the heart in a process over time. Strain
and strain rate is a new technology in echocardiography that has had very
limited pediatric study.
Bodtke enrolled 46 patients within his study and has examined
these results collectively with several cardiologists in the ACH Heart Station. In
addition to Bodtke’s study, several cardiologists have also begun studies
utilizing this data and its significance to cardiac transplant rejection.
Jim has been dedicated to achieving our long-term goals of excellence in
pediatric echocardiography research.
Sherrie Loyd
Director, Ambulatory Cardiac Services
Cardiology Clinic, Heart Station
Cardiac Cath Lab/Electrophysiology Lab
Arkansas Children’s Hospital
Back to Top
|